Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4-positive T Cell Activation via TB10.4 Antigen Presentation (TB10.4-CD4+ T cell activation)
- Target
- TB10.4-CD4+ T cell activation
- Molecular classification
- Immune cell activation, Antigen presentation, T cell signaling
01
Overview
CD4-positive T cell activation via TB10.4 antigen presentation refers to the process by which CD4+ T helper cells are specifically activated in response to the Mycobacterium tuberculosis (Mtb) antigen known as TB10.4. This process is central to mounting an adaptive immune response against Mtb infection, involving antigen processing by APCs, MHC-II presentation, TCR/CD4 engagement, costimulation, and downstream signaling leading to T cell proliferation, differentiation, and cytokine secretion. TB10.4 is an immunodominant antigen recognized by both CD4+ and CD8+ T cells. Variations in processing or sequence polymorphisms within antigens like TB10.4 can shift immunodominance patterns. Full activation requires specific recognition through the peptide/MHC-TCR axis and costimulatory signals; otherwise tolerance may be induced.
- Other names
- TB10.4-specific CD4+ T cell activationTB10.4 antigen presentation to CD4+ T cellsMtb TB10.4-mediated CD4+ T cell response
02
Mechanism of action
N/A
03
Biological functions
T cell activationAdaptive immunityCytokine productionMacrophage activationImmune response to Mycobacterium tuberculosis
04
Disease associations
TuberculosisInfection
05
Safety considerations
Potential for excessive inflammationRisk of immune-mediated pathology
06
Biomarkers
TB10.4-specific T cell frequencyTB10.4-induced cytokine production (e.g., IFN-γ, TNF-α)MHC-II/TB10.4 peptide complex expression
Beyond the preview
Go deeper on CD4-positive T Cell Activation via TB10.4 Antigen Presentation (TB10.4-CD4+ T cell activation).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CD4-positive T Cell Activation via TB10.4 Antigen Presentation (TB10.4-CD4+ T cell activation).